Vr Adviser, LLC Trevi Therapeutics, Inc. Transaction History
Vr Adviser, LLC
- $966 Million
- Q3 2024
A detailed history of Vr Adviser, LLC transactions in Trevi Therapeutics, Inc. stock. As of the latest transaction made, Vr Adviser, LLC holds 3,422,656 shares of TRVI stock, worth $13.9 Million. This represents 1.18% of its overall portfolio holdings.
Number of Shares
3,422,656
Previous 3,422,637
-0.0%
Holding current value
$13.9 Million
Previous $10.2 Million
12.08%
% of portfolio
1.18%
Previous 1.12%
Shares
5 transactions
Others Institutions Holding TRVI
# of Institutions
94Shares Held
57.1MCall Options Held
136KPut Options Held
5.4K-
Nea Management Company, LLC Timonium, MD11.4MShares$46.1 Million2.9% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA7.38MShares$29.9 Million1.33% of portfolio
-
Rubric Capital Management LP New York, NY5.03MShares$20.4 Million0.47% of portfolio
-
Viking Global Investors LP4.4MShares$17.8 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.26MShares$13.2 Million0.0% of portfolio
About Trevi Therapeutics, Inc.
- Ticker TRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,322,500
- Market Cap $236M
- Description
- Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions. The company is developing Haduvio, an oral extended-release formulation of nalbuphine, which is in phase IIb/III clinical trial for the treatment of chronic pruritu...